Overactivated Neddylation Pathway as a Therapeutic Target in Lung Cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overactivated Neddylation Pathway as a Therapeutic Target in Lung Cancer
Authors
Keywords
-
Journal
JNCI-Journal of the National Cancer Institute
Volume 106, Issue 6, Pages -
Publisher
Oxford University Press (OUP)
Online
2014-05-23
DOI
10.1093/jnci/dju083
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Induction of p21-Dependent Senescence by an NAE Inhibitor, MLN4924, as a Mechanism of Growth Suppression
- (2015) Lijun Jia et al. NEOPLASIA
- Update in Lung Cancer and Mesothelioma 2012
- (2013) Charles A. Powell et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pharmacological Inactivation of Skp2 SCF Ubiquitin Ligase Restricts Cancer Stem Cell Traits and Cancer Progression
- (2013) Chia-Hsin Chan et al. CELL
- FBW7 regulates endothelial functions by targeting KLF2 for ubiquitination and degradation
- (2013) Rui Wang et al. CELL RESEARCH
- Molecular Biology of Lung Cancer
- (2013) Serge Patrick Nana-Sinkam et al. CHEST
- Negative Regulation of NEDD8 Conjugation Pathway by Novel Molecules and Agents for Anticancer Therapy
- (2013) Tomoaki Tanaka et al. CURRENT PHARMACEUTICAL DESIGN
- NEDD8 Ultimate Buster-1 Long (NUB1L) Protein Promotes Transfer of NEDD8 to Proteasome for Degradation through the P97UFD1/NPL4Complex
- (2013) Shuai Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- c-Cbl-Mediated Neddylation Antagonizes Ubiquitination and Degradation of the TGF-β Type II Receptor
- (2013) Wei Zuo et al. MOLECULAR CELL
- Treatment-Emergent Mutations in NAEβ Confer Resistance to the NEDD8-Activating Enzyme Inhibitor MLN4924
- (2012) Michael A. Milhollen et al. CANCER CELL
- The Nedd8-Activating Enzyme Inhibitor MLN4924 Induces Autophagy and Apoptosis to Suppress Liver Cancer Cell Growth
- (2012) Z. Luo et al. CANCER RESEARCH
- Novel DNA Damage Checkpoints Mediating Cell Death Induced by the NEDD8-Activating Enzyme Inhibitor MLN4924
- (2012) J. L. Blank et al. CANCER RESEARCH
- Induction of autophagy and senescence by knockdown of ROC1 E3 ubiquitin ligase to suppress the growth of liver cancer cells
- (2012) D Yang et al. CELL DEATH AND DIFFERENTIATION
- NEDDylation regulates E2F-1-dependent transcription
- (2012) Sarah J Loftus et al. EMBO REPORTS
- Inhibition of the Nedd8 System Sensitizes Cells to DNA Interstrand Cross-linking Agents
- (2012) Y. Kee et al. MOLECULAR CANCER RESEARCH
- WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells
- (2012) C Mackintosh et al. ONCOGENE
- The p21-Dependent Radiosensitization of Human Breast Cancer Cells by MLN4924, an Investigational Inhibitor of NEDD8 Activating Enzyme
- (2012) Dong Yang et al. PLoS One
- Targeting Cullin-RING ligases by MLN4924 induces autophagy via modulating the HIF1-REDD1-TSC1-mTORC1-DEPTOR axis
- (2012) Y Zhao et al. Cell Death & Disease
- A Gatekeeper Residue for NEDD8-Activating Enzyme Inhibition by MLN4924
- (2012) Julia I. Toth et al. Cell Reports
- Radiosensitization of Human Pancreatic Cancer Cells by MLN4924, an Investigational NEDD8-Activating Enzyme Inhibitor
- (2011) D. Wei et al. CANCER RESEARCH
- Roles of COP9 signalosome in cancer
- (2011) Mong-Hong Lee et al. CELL CYCLE
- Murine double minute 2 regulates Hu antigen R stability in human liver and colon cancer through NEDDylation
- (2011) Nieves Embade et al. HEPATOLOGY
- Stereoselective Synthesis of MLN4924, an Inhibitor of NEDD8-Activating Enzyme
- (2011) Hyuk Woo Lee et al. JOURNAL OF ORGANIC CHEMISTRY
- MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF- B-dependent lymphoma
- (2010) M. A. Milhollen et al. BLOOD
- NEDD8-Targeting Drug MLN4924 Elicits DNA Rereplication by Stabilizing Cdt1 in S Phase, Triggering Checkpoint Activation, Apoptosis, and Senescence in Cancer Cells
- (2010) J. J. Lin et al. CANCER RESEARCH
- Validation of SAG/RBX2/ROC2 E3 Ubiquitin Ligase as an Anticancer and Radiosensitizing Target
- (2010) L. Jia et al. CLINICAL CANCER RESEARCH
- Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence
- (2010) Hui-Kuan Lin et al. NATURE
- ROC1/RBX1 E3 Ubiquitin Ligase Silencing Suppresses Tumor Cell Growth via Sequential Induction of G2-M Arrest, Apoptosis, and Senescence
- (2009) L. Jia et al. CANCER RESEARCH
- An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
- (2009) Teresa A. Soucy et al. NATURE
- Novel substrates and functions for the ubiquitin-like molecule NEDD8: Figure 1
- (2008) Dimitris P. Xirodimas BIOCHEMICAL SOCIETY TRANSACTIONS
- Ribosomal proteins are targets for the NEDD8 pathway
- (2008) Dimitris P Xirodimas et al. EMBO REPORTS
- Dcn1 Functions as a Scaffold-Type E3 Ligase for Cullin Neddylation
- (2008) Thimo Kurz et al. MOLECULAR CELL
- Multimodal Activation of the Ubiquitin Ligase SCF by Nedd8 Conjugation
- (2008) Anjanabha Saha et al. MOLECULAR CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started